Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$7.87 - $15.15 $4,643 - $8,938
-590 Closed
0 $0
Q2 2021

Jul 08, 2021

SELL
$12.22 - $15.79 $44,126 - $57,017
-3,611 Reduced 85.96%
590 $9,000
Q4 2020

May 19, 2021

BUY
$11.65 - $22.07 $6,873 - $13,021
590 Added 16.34%
4,201 $61,000
Q1 2020

Sep 07, 2021

BUY
$5.27 - $10.41 $19,029 - $37,590
3,611 New
3,611 $28,000

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $27.7M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.